Acasti Pharma Inc.

Q2 2019 13F Holders

Symbol
ACST
CUSIP
00430K402
Type
Equity
Class
CL A NEW
Num filings
13
Total reported value, excl. options
$2.87 M
Manager Report Date Value ($000) Shares Option Type